Drugs Made In Stock Market Value
| DMII Stock | 10.01 0.01 0.10% |
| Symbol | Drugs |
Is there potential for Diversified Capital Markets market expansion? Will Drugs introduce new products? Factors like these will boost the valuation of Drugs Made. Projected growth potential of Drugs fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Drugs Made listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Drugs Made In's market price often diverges from its book value, the accounting figure shown on Drugs's balance sheet. Smart investors calculate Drugs Made's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Drugs Made's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Drugs Made's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Drugs Made should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Drugs Made's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Drugs Made 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Drugs Made's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Drugs Made.
| 11/21/2025 |
| 02/19/2026 |
If you would invest 0.00 in Drugs Made on November 21, 2025 and sell it all today you would earn a total of 0.00 from holding Drugs Made In or generate 0.0% return on investment in Drugs Made over 90 days. Drugs Made is related to or competes with Inflection Point, GigCapital7 Corp, Diamond Hill, M3 Brigade, Axiom Intelligence, and Trailblazer Acquisition. Drugs Made is entity of United States. It is traded as Stock on NASDAQ exchange. More
Drugs Made Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Drugs Made's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Drugs Made In upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 0.1663 | |||
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 0.9098 | |||
| Value At Risk | (0.10) | |||
| Potential Upside | 0.3036 |
Drugs Made Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Drugs Made's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Drugs Made's standard deviation. In reality, there are many statistical measures that can use Drugs Made historical prices to predict the future Drugs Made's volatility.| Risk Adjusted Performance | 0.0868 | |||
| Jensen Alpha | 0.0136 | |||
| Total Risk Alpha | 0.0072 | |||
| Sortino Ratio | (0.14) | |||
| Treynor Ratio | 3.62 |
Drugs Made February 19, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0868 | |||
| Market Risk Adjusted Performance | 3.63 | |||
| Mean Deviation | 0.0958 | |||
| Downside Deviation | 0.1663 | |||
| Coefficient Of Variation | 597.35 | |||
| Standard Deviation | 0.142 | |||
| Variance | 0.0202 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | 0.0136 | |||
| Total Risk Alpha | 0.0072 | |||
| Sortino Ratio | (0.14) | |||
| Treynor Ratio | 3.62 | |||
| Maximum Drawdown | 0.9098 | |||
| Value At Risk | (0.10) | |||
| Potential Upside | 0.3036 | |||
| Downside Variance | 0.0276 | |||
| Semi Variance | (0.02) | |||
| Expected Short fall | (0.18) | |||
| Skewness | 0.734 | |||
| Kurtosis | 3.59 |
Drugs Made In Backtested Returns
Drugs Made is very steady at the moment. Drugs Made In secures Sharpe Ratio (or Efficiency) of 0.18, which denotes the company had a 0.18 % return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Drugs Made In, which you can use to evaluate the volatility of the firm. Please confirm Drugs Made's Coefficient Of Variation of 597.35, mean deviation of 0.0958, and Standard Deviation of 0.142 to check if the risk estimate we provide is consistent with the expected return of 0.0248%. Drugs Made has a performance score of 14 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.0038, which means not very significant fluctuations relative to the market. As returns on the market increase, Drugs Made's returns are expected to increase less than the market. However, during the bear market, the loss of holding Drugs Made is expected to be smaller as well. Drugs Made In right now shows a risk of 0.14%. Please confirm Drugs Made In expected short fall, and the relationship between the value at risk and rate of daily change , to decide if Drugs Made In will be following its price patterns.
Auto-correlation | 0.52 |
Modest predictability
Drugs Made In has modest predictability. Overlapping area represents the amount of predictability between Drugs Made time series from 21st of November 2025 to 5th of January 2026 and 5th of January 2026 to 19th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Drugs Made In price movement. The serial correlation of 0.52 indicates that about 52.0% of current Drugs Made price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.52 | |
| Spearman Rank Test | 0.69 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Drugs Made Correlation, Drugs Made Volatility and Drugs Made Performance module to complement your research on Drugs Made. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Drugs Made technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.